Phase I Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-526168-19-00

Enrollment

142

Registered

2026-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonorrhea

None listed

Sex/Gender

All

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: Jul 8, 2026